...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Journal of contemporary health law and policy. >Unlikely splicing: the Myriad decision, the Genomic Research and Accessibility Act, orphan diseases, and the future of antisense drugs.
【24h】

Unlikely splicing: the Myriad decision, the Genomic Research and Accessibility Act, orphan diseases, and the future of antisense drugs.

机译：不太可能进行拼接：无数的裁决，《基因组研究和可及性法案》，孤儿疾病以及反义药物的未来。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

"Last week, a federal judge threw out patents on two genes linked to cancer," declared comedian and satirist Stephen Colbert on his television show, The Colbert Report, in early 2010. "This is a huge blow to the biotech industry," because, after all, "why cure cancer if you can't make a buck off of it?" Colbert then expressed concern over the ruling's effect on his own patented genetic material, which he had supposedly planned to sell, and worried that "anyone could make a cheap knockoff."Levity aside, the issue of gene patenting is a complex matter that defies simplistic analysis and could significantly affect the future development of life-saving therapeutics. The United States Department of Justice ("DOJ") has stated that the issue of patenting basic discoveries in genetics "is a question of great importance to the national economy, to medical science, and to the public health."
机译：喜剧演员兼讽刺作家斯蒂芬·科尔伯特（Stephen Colbert）在2010年初的电视节目《科尔伯特报告》（The Colbert Report）中宣称：“上周，一位联邦法官宣布了与癌症有关的两个基因的专利。这对生物技术产业是巨大的打击，”毕竟，“如果不能赚钱，为什么要治愈癌症呢？”科尔伯特随后对裁定对他本来计划出售的自己的专利遗传材料的影响表示关注，并担心“任何人都可以做出便宜的仿制品。”除了生命，基因专利的问题是一个复杂的问题，不能简单化。分析，可能会严重影响救生疗法的未来发展。美国司法部（“ DOJ”）表示，对遗传学中的基本发现申请专利的问题“是对国民经济，医学和公共卫生极为重要的问题”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号